Navigation Links
N-Viro International Corporation Announces Dismissal of Lawsuit Against It
Date:10/16/2007

TOLEDO, Ohio, Oct. 16 /PRNewswire-FirstCall/ -- N-Viro International Corp. (OTC Bulletin Board: NVIC) ("N-Viro") announced today that it had achieved the dismissal of a lawsuit in favor of N-Viro and certain past and/or current officers and directors. The action was originally brought in July 2006 by the former CEO, President and Chairman of the Board of N-Viro, J. Patrick Nicholson. In its order granting the dismissal, the Honorable James G. Carr, Chief Judge for the Federal District Court for the Northern District of Ohio, determined that the claims of the plaintiffs were not timely brought and that the plaintiffs' failed to serve properly certain defendants. In addition, the court concluded that the plaintiffs failed to identify any specific statements by N-Viro that were false and misleading and failed to prove that the required inference of scienter.

With the dismissal, N-Viro has prevailed in all actions brought by Mr. Nicholson against N-Viro and its officers and directors. Earlier this year, N-Viro was successful in an arbitration action brought by Mr. Nicholson regarding its termination of a consulting agreement in 2005. In that case, the arbitrator ruled that N-Viro was legally justified in its termination for cause of Mr. Nicholson's consulting agreement. Now his federal action has similarly ended in favor of the Company.

Timothy R. Kasmoch, CEO and President, had these comments: "Mr. Nicholson, through his onslaught of litigation, has wasted company resources. But, we were never distracted from our vision for the future. We will continue to develop our patented N-Viro Fuels technology and believe that N- Viro shareholders will be rewarded. N-Viro is a great company. With positive and honest leadership, I believe great things are possible for N-Viro."

About NVIC

N-Viro International Corporation develops and licenses its technology to municipalities and private companies. N-Viro's patented processes use lime and/or mineral-ri
'/>"/>

SOURCE N-Viro International Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Olympics of biotechnology has international flavor
2. Traffic data firm navigates international business
3. Catalyst International profit exceeds expectations
4. Lack of broadband hamstrings international videoconferencing
5. 30 days to success: Three simple steps to create your own international startup
6. TEKLYNX International announces new RFID software
7. Ruling enforces international trademark electronic filing requirements
8. Eleftheriou to lead Catalyst International
9. Internet trademark war goes international
10. International eyes drawn to Madisons games research
11. Plexus and SRI International team up to offer medical product development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Dec. 3 VIA Pharmaceutic...y focused on the development of compounds for the ... today announced that it has completed the last pa...of VIA-2291. ,, The FDG-PET trial enrolled 52 ...US and Canada including Massachusetts General Hosp...
(Date:12/3/2009)... DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Sus...enzhen Beike Biotechnology Co. Ltd.,( http://www.b...Risk Diabetic,Foot Care in New Delhi, India, Novem...esearch and regenerative medicine company. , ...ry Association (IPA), aimed,to help podiatrists an...
(Date:12/2/2009)... Dec. 2 Reportlinker.com announces... its catalogue: ,, Drug Discovery Technologies...ities ,, http://www.reportlinker.com/p0164246...Market-Trends--Opportunities.html ,, Drug disc...f every pharmaceutical company,s business strategy...
(Date:12/2/2009)..., Gabon, December 2 , - "...lem and Heritage" , Coinciding with the I...he,Gabonese Republic is hosting an international c...feguarding biological resources in Africa. The,con...eaders, ministers,scientific experts, private com...
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Libreville International Conference 2-3 June 2010 2
...AL FUELS INDUSTRIES, INC. (Pink Sheets: VGPR) toda... rating for the Company to "Fully Compliant", its ...TC Markets categorizes all securities trading over...nform investors whether an issuer has made adequat... Subsequent to NFI,s recent filing, Pink OTC Mark...
...ing Drives Aggressive Conversion Program , , ST. ...rovider of cell culture materials and services for...aceutical industry and a business segment within S...q: SIAL ), today announced it has completed the ...ntinuous milling production site in Lenexa, Kansas...
...ucralose manufacturer Guangdong Food Industry Inst...p;P) today announced that the U.S. International T...ded the target date of its final decision in the s...tion 337 patent dispute (docket# 337-TA-604) was f...ate & Lyle Corporation (T&L) , ...
Other Biology Technology:Pink OTC Markets Moves Natural Fuels Industries to Top Tier 2SAFC Biosciences(TM) Completes Conversion of Lenexa Media Milling Facility to Animal Component Free 2SAFC Biosciences(TM) Completes Conversion of Lenexa Media Milling Facility to Animal Component Free 3SAFC Biosciences(TM) Completes Conversion of Lenexa Media Milling Facility to Animal Component Free 4GDFII/L&P Confirms Target Date Extension Of U.S. ITC Sucralose Ruling 2
(Date:12/3/2009)... , ALBUQUERQUE, N.M. Most scientists believe tha...lls that signal each other to emit toxins. The sig...ny bacteria must be present to start the process. ...ined that the very first stage of staph infection,...t form, occurs in a single cell and that this indi...
(Date:12/3/2009)... , Spanish researchers have measured CO2 levels f...atmosphere) over a sparsely inhabited rural area n...f their kind in the Iberian Peninsula, show that t...05. , Over recent years, physicists and meteorol...ioxide (CO2) levels, and how these have evolved in...
(Date:12/2/2009)... , PHILADELPHIA Less acculturated Latino men h...ose who are more acculturated to U.S. culture, but...itting smoking. Details of these findings are publ...tion , a journal of the American Association for C...ocus on tobacco. , "Acculturation affects smokin...
Breaking Biology News(10 mins):Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3CO2 levels rising in troposphere over rural areas 2Acculturation affects smoking cessation success among Latinos 2Anthem Blue Cross and Blue Shield in New Hampshire Gives Boost to Help Small Businesses in the Granite State 51933 1Anthem Blue Cross and Blue Shield in New Hampshire Gives Boost to Help Small Businesses in the Granite State 51933 2Anthem Blue Cross and Blue Shield in New Hampshire Gives Boost to Help Small Businesses in the Granite State 51933 3House Health Reform Bill Would Deliver on President Obamas Vision Says Campaign for Americas Future 51930 1New Lewin Report Shows Need for National Medicaid Out of Network Claims Policy 51927 1New Lewin Report Shows Need for National Medicaid Out of Network Claims Policy 51927 2
...d in textbooks, are essential for eukaryotic cells...ts of energy as they use oxygen. However, some euk...mans--such as Entamoeba histolytica, the causal ag...t are too oxygen poor to support this process. Nev...terious organelle, called a mitosome, that is evol...
...ate student may have figured out why rates of exti... marine life during one of the greatest ice ages o...to 290 million years ago, late in the Paleozoic Er... forms that did survive during this era were singu...mperature and sea levels. Those that were not died...
...identifies 34 regions worldwide where 75 percent o... amphibians survive within habitat covering just 2...ent to the combined areas of the five largest U.S....cent of the Earth,s surface, an area equivalent in...alysis shows that an estimated 50 percent of all v...
Other Biology News:Low level of extinction during ice age linked to adaptability 2Biodiversity hotspots identify conservation priorities 2Biodiversity hotspots identify conservation priorities 3Biodiversity hotspots identify conservation priorities 4Biodiversity hotspots identify conservation priorities 5
PRO S-7C Stirrer, Ceramic Top, 115 V from PRO Scientific
Agencourt AMPure 450ml Kit from Agencourt Bioscience
Pyrex brand baffled trypsinizing flask, with beaded neck from Sigma-Aldrich
...lizing 50g of purified RNA samples for RT-PCR and ... all of the advantages and applications you expect... be used for enzymatic applications such as RT-PCR...imised for the stabilization of aqueous RNA sample...
Biology Products: